Nasdaq:US$20.09 (-0.08) | HKEX:HK$31.55 (-0.50) | AIM:£3.24 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

1 items
a070702